Evidence map›Paper›PMID 33033832›Full record

ArticleThe Journal of infectious diseases2022

Rotavirus Genotypes in Hospitalized Children With Acute Gastroenteritis Before and After Rotavirus Vaccine Introduction in Blantyre, Malawi, 1997-2019.

Chimwemwe Mhango, Jonathan J Mandolo, End Chinyama, Richard Wachepa, Oscar Kanjerwa, Chikondi Malamba-Banda, Prisca B Matambo, Kayla G Barnes, Chrispin Chaguza, Isaac T Shawa and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.4field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Distribution ofPathogens (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Contribution of the EuroRotaNet surveillance network to rotavirus strain surveillance in Europe.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Phylodynamic characteristics of reassortant DS-1-like G3P[8]-strains of rotavirus type A isolated in Nizhny Novgorod (Russia).Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 4 countries.

Chimwemwe MhangoMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Jonathan J MandoloMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
End ChinyamaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Richard WachepaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Oscar KanjerwaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Chikondi Malamba-BandaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Prisca B MatamboMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Kayla G BarnesDepartment of Immunology and Infectious Diseases, T. H. Chan School of Public Health, Harvard University, Boston, Massachusetts, USA.
Chrispin ChaguzaGenomics of Pneumonia and Meningitis, Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, United Kingdom.
Isaac T ShawaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Martin M NyagaNext Generation Sequencing Unit and Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa.
Daniel HungerfordCentre for Global Vaccine Research, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.ORCID 0000-0002-9770-0163
Umesh D ParasharEpidemiology Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Virginia E PitzerDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, Yale University, New Haven, Connecticut, USA.
Arox W Kamng'onaMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.
Miren Iturriza-GomaraCentre for Global Vaccine Research, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Nigel A CunliffeCentre for Global Vaccine Research, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
Khuzwayo C JereMalawi-Liverpool-Wellcome Trust Clinical Research Programme, Blantyre, Malawi.ORCID 0000-0003-3376-8529
University of Liverpool · GBCenters for Disease Control and Prevention · USHarvard University · USUniversity of the Free State · ZAWellcome Sanger Institute · GBYale University · US

Funding

Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countriesR01AI112970 · NIAID · YALE UNIVERSITY · PI PITZER, VIRGINIA E · 2015 to 2024
$4.1M
Department of Health PDF-2018-11-ST2-006NIAID NIH HHS R01 AI112970Wellcome TrustWellcome Trust 091909/Z/10/Z
6 · The paper itself

Abstract

backgroundRotavirus vaccine (Rotarix [RV1]) has reduced diarrhea-associated hospitalizations and deaths in Malawi. We examined the trends in circulating rotavirus genotypes in Malawi over a 22-year period to assess the impact of RV1 introduction on strain distribution.

methodsData on rotavirus-positive stool specimens among children aged <5 years hospitalized with diarrhea in Blantyre, Malawi before (July 1997-October 2012, n = 1765) and after (November 2012-October 2019, n = 934) RV1 introduction were analyzed. Rotavirus G and P genotypes were assigned using reverse-transcription polymerase chain reaction.

resultsA rich rotavirus strain diversity circulated throughout the 22-year period; Shannon (H') and Simpson diversity (D') indices did not differ between the pre- and postvaccine periods (H' P < .149; D' P < .287). Overall, G1 (n = 268/924 [28.7%]), G2 (n = 308/924 [33.0%]), G3 (n = 72/924 [7.7%]), and G12 (n = 109/924 [11.8%]) were the most prevalent genotypes identified following RV1 introduction. The prevalence of G1P[8] and G2P[4] genotypes declined each successive year following RV1 introduction, and were not detected after 2018. Genotype G3 reemerged and became the predominant genotype from 2017 onward. No evidence of genotype selection was observed 7 years post-RV1 introduction.

conclusionsRotavirus strain diversity and genotype variation in Malawi are likely driven by natural mechanisms rather than vaccine pressure.

Indexed as

GastroenteritisRotavirusRotavirus InfectionsRotavirus VaccinesChildChild, HospitalizedDiarrheaFecesGenotypeHumansInfantMalawiRotavirus VaccinesAfricagastroenteritisgenotypesMalawirotavirussurveillance

Identifiers

PMID33033832
PMCPMC9200156
OpenAlexW3092268745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.